SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis study tests a new antibody drug, acasunlimab, in people with advanced solid tumors that have not responded to standard treatments. The first part checks safety and finds the best dose, while the second part tests how well it works alone or with other cancer drugs. About 429 …
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 26, 2026 09:02 UTC
-
Immunotherapy drug may delay cancer return in head and neck patients
Disease control OngoingThis study tests whether the immunotherapy drug pembrolizumab, given after salvage surgery, can help keep head and neck cancer from coming back in people whose cancer has already returned. About 27 adults with squamous cell carcinoma of the head and neck will receive the drug and…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: Assuntina G. Sacco, MD • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
New combo therapy shows promise for Tough-to-Treat head and neck cancer
Disease control OngoingThis study tests whether adding the experimental drug monalizumab to the standard drug cetuximab helps people with advanced head and neck cancer live longer. About 370 adults whose cancer returned or spread after prior treatments, including immunotherapy, will receive either the …
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 08:56 UTC
-
New drug cocktail shows promise against head and neck cancer
Disease control ENROLLING_BY_INVITATIONThis study tests whether combining two drugs, pertuzumab and lenvatinib, given before surgery can shrink advanced head and neck cancer tumors. About 30 adults with newly diagnosed, untreated cancer will receive the drug combination. The goal is to see how many patients have a com…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Can a shot into the tumor boost immunity before surgery?
Knowledge-focused OngoingThis early-stage study looks at whether injecting the drug ipilimumab directly into head and neck tumors before surgery is safe and practical. About 18 adults with squamous cell carcinoma of the head and neck will receive the injection, then have their tumor removed as planned. R…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1 • Sponsor: Providence Health & Services • Aim: Knowledge-focused
Last updated May 26, 2026 09:07 UTC
-
Scientists track Cancer's genetic shifts during therapy in new study
Knowledge-focused OngoingThis study looks at how certain cancers (head and neck, esophagus, and anal canal) change at the genetic and immune level when patients receive chemotherapy or immunotherapy. Researchers collect blood and tumor samples before and during treatment to track these changes. The goal …
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 26, 2026 08:59 UTC